Proapoptotic and prepulse inhibition (PPI) disrupting effects of Hypericum perforatum in rats
- PMID: 19171186
- DOI: 10.1016/j.jep.2009.01.009
Proapoptotic and prepulse inhibition (PPI) disrupting effects of Hypericum perforatum in rats
Abstract
Ethnopharmacological relevance: St. John's wort extract is commonly used as a wound healing, anti-inflammatory, anxiolytic, diuretic, antibiotic, antiviral and cancer chemoprotective agent. It also has nootropic and/or antiamnestic effects.
Aim of the study: Prepulse inhibition (PPI) of startle response is a valuable paradigm for sensorimotor gating processes. A previous study indicated that single administration of St. John's wort extract (500 mg/kg) caused PPI disruption in rats. The effect of antiamnestic doses of the extract on PPI has not been investigated despite the coexistence of impaired memory and PPI deficit in some neurological disorders.
Materials and methods: The effects of acute (500 mg/kg) and chronic (200mg/kg for 3 days) administration of St. John's wort extract were investigated for its antiamnestic activity. The effects of administration of the antiamnestic dose of the extract and hyperforin, its main active component, were tested on PPI of an acoustic startle response in rats. This study also investigated the proapoptotic effect of hyperforin in animals, demonstrating PPI deficit, by electrophoresis of DNA isolated from selected brain areas.
Results: Disruption of PPI resulted after treatment of rats with an antiamnestic dose of the extract (200mg/kg for 3 days) and with hyperforin. Gel electrophoresis showed DNA fragmentation of the cortices of hyperforin-treated animals exhibiting PPI deficit.
Conclusions: The exacerbating effect of St. John's wort extract on PPI deficit may provide a limitation for using the extract to manage cognitive disturbance in psychotic and Huntington's disease patients manifesting PPI deficit.
Similar articles
-
Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.Behav Brain Res. 2009 May 16;199(2):334-9. doi: 10.1016/j.bbr.2008.12.015. Epub 2008 Dec 24. Behav Brain Res. 2009. PMID: 19136030
-
Neural monoaminergic mediation of the effect of St. John's wort extract on prepulse inhibition of the acoustic startle response in rats.J Psychopharmacol. 2005 Sep;19(5):467-72. doi: 10.1177/0269881105056522. J Psychopharmacol. 2005. PMID: 16166183
-
Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.Int J Biochem Cell Biol. 2008;40(8):1509-21. doi: 10.1016/j.biocel.2007.11.019. Epub 2007 Dec 8. Int J Biochem Cell Biol. 2008. PMID: 18226577
-
[Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].Ceska Slov Farm. 2007 Apr;56(2):62-6. Ceska Slov Farm. 2007. PMID: 17619301 Review. Czech.
-
Current St John's wort research from mode of action to clinical efficacy.Pharmacol Res. 2003 Feb;47(2):101-9. doi: 10.1016/s1043-6618(02)00266-9. Pharmacol Res. 2003. PMID: 12543057 Review.
Cited by
-
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019.Pharmaceuticals (Basel). 2023 Mar 29;16(4):508. doi: 10.3390/ph16040508. Pharmaceuticals (Basel). 2023. PMID: 37111265 Free PMC article.
-
Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice.Pharmacol Biochem Behav. 2012 Mar;101(1):107-14. doi: 10.1016/j.pbb.2011.12.010. Epub 2011 Dec 21. Pharmacol Biochem Behav. 2012. PMID: 22210488 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials